BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $100 at BMO Capital
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $66.99 +0.53%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
BMO Capital analyst Kostas Biliouris lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 (from $102.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BMO Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform
- CrowdStrike (CRWD) PT Raised to $250 at Benchmark Ahead of Q2 Results
- The Campbell's Co. (CPB) PT Raised to $22 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
